Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mesoblast, Athersys Take Lead In Race To Develop Stem Cell Therapies For COVID-19

Jul 21 2020

• By Bridget Silverman

Related Content

Keeping Track: A Busy Week For Regenerative Medicine, A Surprise Priority Review For Vascepa, And Tazemetostat Aims For Accelerated Approval

Jun 02 2019

Stem Cells For COVID-19: Promising Platform With A ‘Dark Side’

Jul 21 2020

Coronavirus Update: Pfizer And BioNTech Kick Off COVID-19 Trial

May 06 2020

Related Companies

Mesoblast Limited

Hope Biosciences

Celltex Therapeutics Corporation

ImmunityBio Inc.

ImmunityBio

Baylx, Inc.

Athersys, Inc.

Celularity, Inc.

Sorrento Therapeutics, Inc.

Additional Topics

United States Regenerative Medicine Coronavirus COVID-19 Clinical Trials Regulation BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window